These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 22492765)

  • 21. Hope for the future: early recognition of increased cardiovascular risk in children and how to deal with it.
    Masi S; Charakida M; Wang G; O'Neill F; Taddei S; Deanfield J
    Eur J Cardiovasc Prev Rehabil; 2009 Aug; 16 Suppl 2():S61-4. PubMed ID: 19675441
    [No Abstract]   [Full Text] [Related]  

  • 22. Practice guidelines, a new reality in medicine. II. Methods of developing guidelines.
    Woolf SH
    Arch Intern Med; 1992 May; 152(5):946-52. PubMed ID: 1580720
    [TBL] [Abstract][Full Text] [Related]  

  • 23. How to develop guidelines for clinical practice.
    Jaeschke R; Jankowski M; Brozek J; Antonelli M
    Minerva Anestesiol; 2009 Sep; 75(9):504-8. PubMed ID: 19002086
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Use of systemic therapy in women with recurrent ovarian cancer--development of a national clinical practice guideline.
    Elit L; Zitzelsberger L; Fung-Kee-Fung M; Brouwers M; Graham ID; Browman G; Hoskins P; Lau S; Ghatage P;
    Gynecol Oncol; 2007 Jul; 106(1):181-92. PubMed ID: 17498781
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Reassessment of evidence synthesis of occupational medicine practice guidelines for interventional pain management.
    Manchikanti L; Singh V; Derby R; Schultz DM; Benyamin RM; Prager JP; Hirsch JA
    Pain Physician; 2008; 11(4):393-482. PubMed ID: 18690276
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Factors impeding the implementation of cardiovascular prevention guidelines: findings from a survey conducted by the European Society of Cardiology.
    Graham IM; Stewart M; Hertog MG;
    Eur J Cardiovasc Prev Rehabil; 2006 Oct; 13(5):839-45. PubMed ID: 17001227
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Reply concerning the new Medical Products Agency's guidelines for primary prevention of cardiovascular diseases. Issuing recommendations based on available evidence basis an ethical duty].
    Beermann B
    Lakartidningen; 2006 Nov 22-28; 103(47):3731-2. PubMed ID: 17212324
    [No Abstract]   [Full Text] [Related]  

  • 28. The development and peer review of evidence-based guidelines to support midwifery led care in labour.
    Spiby H; Munro J
    Midwifery; 2009 Apr; 25(2):163-71. PubMed ID: 17512101
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Does nurse case management improve implementation of guidelines for cardiovascular disease risk reduction?
    Berra K
    J Cardiovasc Nurs; 2011; 26(2):145-67. PubMed ID: 21076315
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Guidelines on the use of intravenous immune globulin for neurologic conditions.
    Feasby T; Banwell B; Benstead T; Bril V; Brouwers M; Freedman M; Hahn A; Hume H; Freedman J; Pi D; Wadsworth L
    Transfus Med Rev; 2007 Apr; 21(2 Suppl 1):S57-107. PubMed ID: 17397768
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Development of quality indicators for diagnosis and treatment of patients with non-small cell lung cancer: a first step toward implementing a multidisciplinary, evidence-based guideline.
    Hermens RP; Ouwens MM; Vonk-Okhuijsen SY; van der Wel Y; Tjan-Heijnen VC; van den Broek LD; Ho VK; Janssen-Heijnen ML; Groen HJ; Grol RP; Wollersheim HC
    Lung Cancer; 2006 Oct; 54(1):117-24. PubMed ID: 16920220
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Guidelines for pharmacological primary prevention of cardiovascular diseases--who should be treated?].
    Fretheim A; Bjørndal A; Oxman AD; Dyrdal A; Golding M; Ose L; Reikvam A; Teisberg P
    Tidsskr Nor Laegeforen; 2002 Sep; 122(23):2277-81. PubMed ID: 12448268
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Diagnostic imaging practice guidelines for musculoskeletal complaints in adults--an evidence-based approach: introduction.
    Bussières AE; Peterson C; Taylor JA
    J Manipulative Physiol Ther; 2007; 30(9):617-83. PubMed ID: 18082742
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Transforming written guidelines into electronic formats--international perspectives.
    Marshall C; Rosenbrand K; Ollenschlaeger G
    Stud Health Technol Inform; 2004; 101():123-6. PubMed ID: 15537213
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Tricyclic antidepressant poisoning: an evidence-based consensus guideline for out-of-hospital management.
    Woolf AD; Erdman AR; Nelson LS; Caravati EM; Cobaugh DJ; Booze LL; Wax PM; Manoguerra AS; Scharman EJ; Olson KR; Chyka PA; Christianson G; Troutman WG
    Clin Toxicol (Phila); 2007; 45(3):203-33. PubMed ID: 17453872
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Guidelines on the use of intravenous immune globulin for hematologic conditions.
    Anderson D; Ali K; Blanchette V; Brouwers M; Couban S; Radmoor P; Huebsch L; Hume H; McLeod A; Meyer R; Moltzan C; Nahirniak S; Nantel S; Pineo G; Rock G
    Transfus Med Rev; 2007 Apr; 21(2 Suppl 1):S9-56. PubMed ID: 17397769
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cardiovascular risk reduction in high-risk pediatric patients: a scientific statement from the American Heart Association Expert Panel on Population and Prevention Science; the Councils on Cardiovascular Disease in the Young, Epidemiology and Prevention, Nutrition, Physical Activity and Metabolism, High Blood Pressure Research, Cardiovascular Nursing, and the Kidney in Heart Disease; and the Interdisciplinary Working Group on Quality of Care and Outcomes Research.
    Kavey RE; Allada V; Daniels SR; Hayman LL; McCrindle BW; Newburger JW; Parekh RS; Steinberger J; ; ; ; ; ; ; ; ;
    J Cardiovasc Nurs; 2007; 22(3):218-53. PubMed ID: 17545824
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III Guidelines.
    Grundy SM; Cleeman JI; Merz CN; Brewer HB; Clark LT; Hunninghake DB; Pasternak RC; Smith SC; Stone NJ;
    J Am Coll Cardiol; 2004 Aug; 44(3):720-32. PubMed ID: 15358046
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III guidelines.
    Grundy SM; Cleeman JI; Merz CN; Brewer HB; Clark LT; Hunninghake DB; Pasternak RC; Smith SC; Stone NJ;
    Arterioscler Thromb Vasc Biol; 2004 Aug; 24(8):e149-61. PubMed ID: 15297292
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Which cholesterol-lowering drugs should be used in the primary prevention of cardiovascular disease?].
    Fretheim A; Bjørndal A; Oxman AD; Dyrdal A; Golding M; Ose L; Reikvam A; Teisberg P
    Tidsskr Nor Laegeforen; 2002 Sep; 122(23):2287-8. PubMed ID: 12448270
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.